M&A / Deals AstraZeneca, GSK intensify China ties with Sino Biopharm deals BioPharma DiveThe U.K.Read full story pharminent July 8, 2026 (Last updated: July 9, 2026) BioPharma Dive The U.K. Read full story Post navigation Previous: AstraZeneca bets up to $1.9B in respiratory disease collab with Sino BiopharmaceuticalNext: Tanabe pens deal to sell plants to Towa in post-buyout pivot Related Stories M&A / Deals Solstice Oncology secures $225m to drive porustobart’s development for cancer pharminent September 10, 2026 M&A / Deals UK’s Claret Capital raises 575m for European biotechs pharminent September 7, 2026 M&A / Deals GSK wagers up to $1.3B on a different kind of cancer drug pharminent September 3, 2026